Transradial Approach for Neuroendovascular Procedures: A Single-Center Review of Safety and Feasibility.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
01 2021
Historique:
received: 16 06 2020
accepted: 05 09 2020
pubmed: 16 1 2021
medline: 27 4 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

In recent years, the transradial approach has become more widely adopted for neuroendovascular procedures. The purpose of this study was to evaluate the safety and feasibility of a transradial approach and distal transradial access for neuroendovascular procedures in a single center. Retrospective analysis was performed for all patients who underwent transradial approach or distal transradial access neuroendovascular procedures from January 2016 to August 2019 at a single center. Exclusion criteria included a Barbeau D waveform, a radial artery of <2 mm on sonographic evaluation, and known radial artery occlusion. Procedures were evaluated for technical success (defined as successful radial artery access and completion of the intended procedure without crossover to an auxiliary access site), complications, and adverse events during follow-up at 30 days. The transradial approach or distal transradial access was attempted in 279 consecutive patients (58.1% women; median age, 57.7 years) who underwent 328 standard or distal transradial approach procedures. Two-hundred seventy-nine transradial approach and 49 distal transradial approach procedures were performed (cerebral angiography [ The transradial approach for neuroendovascular procedures is safe and feasible across a wide range of neuroendovascular interventions.

Sections du résumé

BACKGROUND AND PURPOSE
In recent years, the transradial approach has become more widely adopted for neuroendovascular procedures. The purpose of this study was to evaluate the safety and feasibility of a transradial approach and distal transradial access for neuroendovascular procedures in a single center.
MATERIALS AND METHODS
Retrospective analysis was performed for all patients who underwent transradial approach or distal transradial access neuroendovascular procedures from January 2016 to August 2019 at a single center. Exclusion criteria included a Barbeau D waveform, a radial artery of <2 mm on sonographic evaluation, and known radial artery occlusion. Procedures were evaluated for technical success (defined as successful radial artery access and completion of the intended procedure without crossover to an auxiliary access site), complications, and adverse events during follow-up at 30 days.
RESULTS
The transradial approach or distal transradial access was attempted in 279 consecutive patients (58.1% women; median age, 57.7 years) who underwent 328 standard or distal transradial approach procedures. Two-hundred seventy-nine transradial approach and 49 distal transradial approach procedures were performed (cerebral angiography [
CONCLUSIONS
The transradial approach for neuroendovascular procedures is safe and feasible across a wide range of neuroendovascular interventions.

Identifiants

pubmed: 33446499
pii: ajnr.A6971
doi: 10.3174/ajnr.A6971
pmc: PMC7872175
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

313-318

Informations de copyright

© 2021 by American Journal of Neuroradiology.

Références

Neurol Res. 2000 Sep;22(6):605-8
pubmed: 11045024
J Invasive Cardiol. 1996;8 Suppl D:40D-44D
pubmed: 10785786
Stroke. 2019 Sep;50(9):2587-2590
pubmed: 31311466
Ann Vasc Surg. 2019 Oct;60:327-334.e2
pubmed: 31200055
Circulation. 2014 Jun 3;129(22):2277-86
pubmed: 24756064
Neurosurgery. 2002 Aug;51(2):335-40; discussion 340-2
pubmed: 12182771
Lancet. 2011 Apr 23;377(9775):1409-20
pubmed: 21470671
J Vasc Interv Radiol. 2016 Feb;27(2):159-66
pubmed: 26706186
EuroIntervention. 2013 Mar;8(11):1242-51
pubmed: 23354100
J Neurointerv Surg. 2020 Aug;12(8):733-741
pubmed: 31818970
J Korean Neurosurg Soc. 2013 Apr;53(4):213-7
pubmed: 23826476
Am Heart J. 2004 Mar;147(3):489-93
pubmed: 14999199
Arq Bras Cardiol. 2015 May;104(5):401-8
pubmed: 25789883
Lancet. 2015 Jun 20;385(9986):2465-76
pubmed: 25791214
Circ Cardiovasc Interv. 2018 Sep;11(9):e000035
pubmed: 30354598
CVIR Endovasc. 2018;1(1):15
pubmed: 30652147
J Neurointerv Surg. 2018 Sep;10(9):874-881
pubmed: 29311120
J Vasc Surg. 2017 Sep;66(3):820-825
pubmed: 28571881
J Neurointerv Surg. 2020 Apr;12(4):431-434
pubmed: 31586940
J Neurointerv Surg. 2019 Oct;11(10):1045-1049
pubmed: 30842303
Catheter Cardiovasc Interv. 2011 Nov 15;78(6):823-39
pubmed: 21544927
J Neurointerv Surg. 2020 Oct;12(10):993-998
pubmed: 31974282
J Vasc Interv Radiol. 2018 Mar;29(3):383-388
pubmed: 29395902
J Am Heart Assoc. 2016 Jan 25;5(1):
pubmed: 26811162
J Neurointerv Surg. 2020 Jan;12(1):82-86
pubmed: 31350370
J Am Coll Cardiol. 2012 Dec 18;60(24):2490-9
pubmed: 23103036
AJNR Am J Neuroradiol. 2001 Apr;22(4):704-8
pubmed: 11290482
EuroIntervention. 2014 Jul;10(3):381-91
pubmed: 25042266
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):454-62
pubmed: 22740010
J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9
pubmed: 22858390
BMJ. 2004 Aug 21;329(7463):443-6
pubmed: 15321904
J Am Coll Cardiol. 2014 Mar 18;63(10):964-72
pubmed: 24211309
JACC Cardiovasc Interv. 2012 Jan;5(1):36-43
pubmed: 22230148
J Neurointerv Surg. 2019 Sep;11(9):874-878
pubmed: 30670623
J Korean Neurosurg Soc. 2010 May;47(5):332-7
pubmed: 20539791

Auteurs

D T Goldman (DT)

From the Departments of Radiology (D.T.G., R.A.D.L.).

D Bageac (D)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

A Mills (A)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

B Yim (B)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

K Yaeger (K)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

S Majidi (S)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

C P Kellner (CP)

Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

R A De Leacy (RA)

From the Departments of Radiology (D.T.G., R.A.D.L.) reade.deleacy@mountsinai.org.
Neurosurgery (D.B., B.Y., K.Y., S.M., C.P.K., R.A.D.L.), Icahn School of Medicine at Mount Sinai (A.M.), New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH